Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Capital Expenditures: 2010-2025

Historic Capital Expenditures for Mesa Laboratories (MLAB) over the last 15 years, with Sep 2025 value amounting to $1.1 million.

  • Mesa Laboratories' Capital Expenditures fell 38.93% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.7 million, marking a year-over-year decrease of 15.45%. This contributed to the annual value of $4.2 million for FY2025, which is 65.52% up from last year.
  • Per Mesa Laboratories' latest filing, its Capital Expenditures stood at $1.1 million for Q3 2025, which was up 8.23% from $1.0 million recorded in Q2 2025.
  • In the past 5 years, Mesa Laboratories' Capital Expenditures ranged from a high of $2.1 million in Q4 2021 and a low of $225,000 during Q2 2022.
  • For the 3-year period, Mesa Laboratories' Capital Expenditures averaged around $903,909, with its median value being $891,000 (2024).
  • As far as peak fluctuations go, Mesa Laboratories' Capital Expenditures soared by 733.60% in 2021, and later slumped by 65.54% in 2022.
  • Quarterly analysis of 5 years shows Mesa Laboratories' Capital Expenditures stood at $2.1 million in 2021, then decreased by 19.67% to $1.7 million in 2022, then plummeted by 31.80% to $1.1 million in 2023, then dropped by 27.93% to $813,000 in 2024, then plummeted by 38.93% to $1.1 million in 2025.
  • Its last three reported values are $1.1 million in Q3 2025, $1.0 million for Q2 2025, and $757,000 during Q1 2025.